Dollar strength sets gold on its longest losing streak since November



* Dollar set for weekly gain

* Gold down 2.9% so far this week

* Silver set for worst week in about 2 years (Updates prices)

By Ashitha Shivaprasad

Aug 19 (Reuters) - Gold prices slipped for a fifth consecutive session on Friday, in its longest losing run since November last year, as the bullion's appeal waned with a stronger dollar and more U.S. interest rate hikes on the horizon.

Spot gold XAU= dropped 0.6% to $1,748.58 per ounce by 1:47 p.m. ET (1747 GMT), having hit its lowest since July 28 earlier in the session. U.S. gold futures GCv1 settled down 0.5% at $1,762.9.

After posting gains in the previous four weeks, prices are down 2.9% so far this week, the most since the week of July 8.

"The main element pressuring gold and silver market is the resurgent dollar... Gold and dollar compete as safe-haven assets, higher U.S. interest rates suggest a stronger dollar, which will add further downside to gold," said Jim Wyckoff, senior analyst at Kitco Metals.

The dollar index .DXY surged and was on track for a weekly gain. Stronger dollar makes gold less attractive for overseas buyers.

The Fed needs to keep raising rates to bring high inflation under control, a string of U.S. central bank officials said on Thursday, even as they debated how fast and how high to lift them.

The reality check on the trajectory of future Fed rate rises has brought an abrupt reversal in gold's attempts to climb back above $1,800, Rupert Rowling, a market analyst at Kinesis Money, wrote in a note.

Investors will be looking downwards to below $1,700 as the next significant support rather than at any upward landmarks, Rowling added.

A drop in domestic prices led to improved gold buying in major consumer India.

Spot silver XAG= fell 2.2% to $19.09 per ounce, en route a fall of 8.3% this week, possibly its worst since September 2020.

Slower economic growth and a Fed that keeps tightening provide an unfavourable mix for silver, UBS analysts said.

Platinum XPT= fell 1.9% to $893.30, while palladium XPD= was down 1.6% to $2,121.23, both set for weekly drops.


Reporting by Ashitha Shivaprasad in Bengaluru; Editing by Krishna Chandra Eluri and Shailesh Kuber

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.